FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

Completed

Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific

In brief

This pilot clinical trial studies fluorine F 18 fluorothymidine (FLT)-positron emission tomography/magnetic resonance imaging (PET/MRI) in measuring early response in patients with metastatic solid tumors receiving treatment that blocks blood flow to the tumor. Diagnostic procedures, such as FLT-PET/MRI, may help measure a patient's response earlier during treatment.

Key facts

Study ID
NCT02055586
Run by
Case Comprehensive Cancer Center
People needed
10
Starts
2013-10-22
Expected to finish
2017-12-27
Last updated by the study team
2020-09-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.